AGIO up +9.20% percent Today $AGIO High is at 93.00 and the

New Post Public Reply Private Reply Replies (0) Message Board

Nov 19, 2014 at 10:31 AM

AGIO up +9.20% percent Today $AGIO High is at 93.00 and the Low 83.68 with current volume of 1,516,641.

Recent News posted below.

Agios Pharmaceuticals Inc AGIO other info.
http://investorshangout.com/Agios-Pharmaceuti...GIO-90049/

AGIO Agios Pharmaceuticals Inc Recent Headline News

Stock Futures Take A Data Dive; Tesla Falls On Outlook Change
at Investor's Business Daily - 1 hr 19 mins ago
Stock futures fell out of flat trade to moderate losses ahead of Wednesday's open after a mixed read on October homebuilding activity. Dow futures slumped 18.8 points below fair market value. Nasdaq 100 futures traded down 6.3 points. S&P 500 futures...
SPLS: 13.98 (+1.22), LEJU: 12.45 (-1.71), TSLA: 248.10 (-9.60), FCAU: 12.18 (-0.63), LITB: 7.75 (+0.11), TTM: 46.46 (-0.70), DL: 17.75 (+2.78), VA: 36.84 (-0.21), TGT: 71.07 (+3.56), GM: 32.10 (-0.17), AGIO: 91.55 (+7.74), LOW: 61.76 (+3.23), HMC: 31.03 (-0.62), EJ: 8.66 (-0.87), PETM: 76.40 (+2.78)

Agios leukemia drug candidate shows clinical activity in Phase 1 trial
Seeking Alpha - at Seeking Alpha - 1 hr 29 mins ago

AGIO: 91.55 (+7.74)

Agios Cancer 'Metabolism' Drug Clears Bone Marrow of Leukemic Cells
at The Street - Tue Nov 18, 5:02PM CST
The experimental drug from Agios, designed to attack the "metabolism" of cancer cells, has demonstrated early but strong clinical responses in a study involving patients with advanced leukemia.
AGIO: 91.55 (+7.74), CELG: 106.02 (-0.76)

Agios Pharmaceuticals Announces Early Phase 1 Data Showing Clinical Activity of AG-120 as a Single Agent in Advanced Acute Myeloid Leukemia (AML)
GlobeNewswire - Tue Nov 18, 5:01PM CST
-Significant Clinical Responses and Reduction of 2HG Biomarker Provide Early Validation of Mutant IDH1 as a Therapeutic Target in AML -
AGIO: 91.55 (+7.74)

Jim Cramer Says to Buy Six Flags, Avoid SeaWorld Entertainment
at The Street - Wed Nov 12, 1:20PM CST
TheStreet's Jim Cramer says investors shouldn't be tricked by SeaWorld's attractive dividend yield. Instead, stick with Six Flags Entertainment.
SEAS: 17.20 (+0.14), SIX: 40.53 (-0.27), AGIO: 91.55 (+7.74)

Nasdaq stocks posting largest percentage increases
AP - Tue Nov 11, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
ICUI: 84.37 (-1.19), OREX: 5.54 (-0.08), PCMI: 8.86 (+0.07), CYAN: 7.69 (-0.15), ACHN: 13.10 (-0.21), TGTX: 14.49 (-0.28), AGIO: 91.70 (+7.89), LIOX: 5.05 (-0.09), SAJA: 5.97 (-0.14), PLNR: 7.23 (-0.16)

Biotech Weekly: When Mid Caps Are Priced Nearly For Perfection
Daniel Ward - at Seeking Alpha - Mon Nov 10, 9:28AM CST

XBI: 170.72 (-0.66), SLXP: 104.96 (-0.43), ICPT: 157.87 (-4.63), IBB: 293.56 (-1.69), AGIO: 91.70 (+7.89)

Agios Pharmaceuticals' (AGIO) CEO David Schenkein on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Sat Nov 08, 6:31AM CST

AGIO: 91.70 (+7.89)

Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 8:14AM CST

BEBE: 2.63 (+0.06), ANET: 76.88 (+0.08), TKMR: 16.11 (-0.26), ORBC: 6.21 (-0.13), MDRX: 12.05 (-0.15), RMTI: 9.99 (-0.29), CTIC: 2.22 (-0.06), SHLD: 35.65 (-0.26), UBNT: 29.30 (-0.29), RIG: 25.29 (-0.56), KGC: 2.85 (-0.11), APT: 2.84 (+0.11), ANF: 28.81 (-0.13), MITK: 3.89 (-0.07), ZNGA: 2.68 (-0.03), CNET: 1.83 (-0.03), KING: 16.07 (-0.03), NETE: 1.35 (unch), SLXP: 104.96 (-0.43), RPRX: 9.07 (-0.12), NADL: 3.71 (-0.26), PGNX: 6.41 (-0.13), AVNR: 13.90 (+0.20), FSLR: 49.01 (-0.45), DVA: 74.97 (-0.26), NDLS: 22.55 (-0.10), ICPT: 157.87 (-4.63), AGIO: 91.55 (+7.74), PLNR: 7.23 (-0.16)

Agios Pharmaceuticals EPS of $0.10
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 6:11AM CST

AGIO: 91.60 (+7.79)

Agios Pharmaceuticals posts 3Q profit
Automated Insights - Fri Nov 07, 6:09AM CST
CAMBRIDGE, Mass. (AP) _ Agios Pharmaceuticals Inc. (AGIO) on Friday reported earnings of $3.7 million, or 10 cents per share, in its third quarter.
AGIO: 91.60 (+7.79)

Agios Pharmaceuticals Reports Third Quarter 2014 Financial Results
GlobeNewswire - Fri Nov 07, 6:00AM CST
Agios Pharmaceuticals, Inc. (Nasdaq:AGIO), a leader in the fields of cancer metabolism and rare genetic disorders of metabolism, today reported business highlights and financial results for the third quarter ended September 30, 2014.
AGIO: 91.60 (+7.79)

Notable earnings before Friday’s open
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 4:30PM CST

BAM: 49.66 (-0.22), ERF: 15.01 (-0.14), LXP: 10.96 (-0.01), PGEM: 12.29 (-0.14), CCOI: 34.99 (-0.16), TTI: 7.99 (-0.17), SJI: 56.40 (-0.15), NXST: 47.08 (-0.32), VSAT: 65.70 (+0.16), MT: 12.28 (-0.17), LXU: 33.33 (-0.40), HUM: 138.11 (-1.18), PGNX: 6.41 (-0.13), MHR: 4.55 (-0.07), CTB: 32.52 (unch), IDRA: 2.54 (+0.06), ISIS: 50.00 (+0.29), BPL: 81.59 (+0.19), SSP: 19.61 (-0.03), AGIO: 91.60 (+7.79), EBIX: 16.10 (-0.13)

Will Agios (AGIO) Disappoint in the Q3 Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 4:10PM CST
Agios (AGIO), which is scheduled to report third-quarter results on Nov 7, had delivered a negative earnings surprise of 14.89% in the last quarter.
MNK: 84.79 (-4.01), RNA: 11.45 (-0.05), AGIO: 91.72 (+7.91), CELG: 106.03 (-0.75)

Agios Pharmaceuticals to Present Clinical and Preclinical Data at the 2014 American Society of Hematology Annual Meeting
GlobeNewswire - Thu Nov 06, 8:46AM CST
New Data from Ongoing Phase 1 AG-221 Trial Accepted for Oral Presentation
AGIO: 91.72 (+7.91)

Critical Alerts For LinkedIn, Imperva Inc, Norfolk Southern, Halliburton and Agios Pharmaceuticals Released By InvestorsObserver
PR Newswire - Mon Nov 03, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for LNKD, IMPV, NSC, HAL and AGIO.
NSC: 114.63 (-0.75), LNKD: 217.10 (-3.97), HAL: 48.15 (-0.39), AGIO: 91.72 (+7.91), IMPV: 41.32 (-1.21)

Super Important Biotech and Drug Stock Events for November
at The Street - Mon Nov 03, 7:24AM CST
A cheat sheet of earnings, medical meetings, FDA approval decisions and clinical trial results for healthcare investors.
GILD: 101.71 (-2.00), CLVS: 50.90 (-2.88), ARWR: 5.95 (unch), ACHN: 13.11 (-0.20), MRK: 59.19 (-0.70), RTRX: 8.90 (-0.13), RGLS: 17.32 (-0.80), EPZM: 23.07 (-0.36), AGIO: 91.72 (+7.91), RMTI: 9.99 (-0.29), ARNA: 4.21 (-0.10), KERX: 15.48 (-0.06)

Cramer's Lightning Round - Isis Pharmaceuticals Has The Best Pipeline (10/28/14)
SA Editor Miriam Metzinger - Seeking Alpha - Wed Oct 29, 5:59AM CDT
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Tuesday October 2 8. Bullish Calls: Isis Pharmaceuticals (NASDAQ: ISIS ): "Isis got slammed, and (the selloff) was overdone. It has the best pipeline...
GS: 189.02 (-0.62), RICE: 25.65 (+0.15), ISIS: 50.00 (+0.29), CYBR: 42.09 (-0.58), GNC: 43.05 (+0.16), HAL: 48.15 (-0.39), AGIO: 91.72 (+7.91), FTNT: 26.55 (-0.40)

'Mad Money' Lightning Round: I'm Sticking With Isis Pharmaceuticals
at The Street - Wed Oct 29, 5:00AM CDT
Cramer says Halliburton is a buy, buy, buy and GNC needs to merge with Vitamin Shoppe.
VSI: 46.24 (-0.17), RICE: 25.65 (+0.15), GS: 189.02 (-0.62), FEYE: 31.30 (-0.57), ISIS: 50.00 (+0.29), CYBR: 42.09 (-0.58), GNC: 43.05 (+0.16), HAL: 48.15 (-0.39), EOG: 97.66 (-0.01), AGIO: 91.72 (+7.91), FTNT: 26.55 (-0.40)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Push Notification Security Transforms Healthcare IT Support

Cutting the Fat on IT Help Desk Bottlenecks Healthcare IT teams are fighting an uphill battle with password resets, a mundane task consuming up to half of all help desk calls. It's like trying to stop a leaking dam with duct tape. For health systems, these calls aren't just a minor annoyance—they're a full-fledged budget hog. Try telling a CIO that an agent-friendly...

Sandbox VR Expands to Melbourne, Betting on Immersive Fun

Sandbox VR Ventures into Melbourne's Heart Every now and then, a venture takes its ambitions and rolls the dice on a prime location. Sandbox VR is swaggering into Melbourne's bustling Central Business District, fresh out of its success on the Gold Coast. Opening this Melbourne venue on September 14 marks a significant leap in the company's Aussie expansion—a bold nod to...

Cove Capital Secures $9.96M for Debt-Free Logistics DST

Unpacking Cove Capital's Latest Victory Cove Capital Investments has pulled off another coup, raising a hefty $9,964,510 for its Cove Essential Net Lease Industrial 108 DST. It's a Regulation D, Rule 506(c) offering, now fully subscribed, spotlighting a debt-free investment ethos and a rock-solid logistics site in Anchorage, Alaska. Strategic Facility Anchoring Investment...

Tampa General’s Innovation Excellence Earns No. 20 Spot

A Bold Leap into Innovation at Tampa General There's a heck of a lot going on down in Tampa that's worth more than just a golf clap. Tampa General Hospital (TGH) just snagged the 20th spot on Fast Company's Best Workplaces for Innovators list, and let me tell you, that’s no small feat amidst the heavy hitters in verticals like biotech and consumer goods. It takes guts...

Cap Juluca: Caribbean Luxury Redefined on Maundays Bay

The Tranquil Call of Maundays Bay Find me dipping my toes in the sands of Maundays Bay come October 10, 2026, and you'll understand why this slice of Anguilla stakes its claim to being the best beach on the globe. Cap Juluca, that crown jewel of Caribbean luxury, swings open its doors once more, promising indulgence framed by turquoise waters and the soft whisper of white...

Global Communication Works Opens SignlLabs™ AI Licensing

AI Signaling Moves Beyond GCW's Own Clients Remember when we first looked at GCW's SignlLabs and the idea of helping brands show up inside ChatGPT, Gemini, Claude, Copilot and Perplexity? Well, Global Communication Works is taking the next step. Instead of keeping its AI Signaling playbook inside the agency walls, GCW is now opening SignlLabs up for licensing

CUBEX Lights Up Veterinary Care with Mini Essential

Inventory Woes? Meet Mini Essential If you’ve ever worked in or around veterinary hospitals, you know the old-school headaches of managing controlled substances. Picture this: piles of paper logs, end-of-shift recounting, and inevitable discrepancies that rear their ugly heads long after closing time. Enter CUBEX, shaking things up with their latest launch, Mini...

Monib Zirvi's Dermatology Excellence Honored in 2026

Trailblazer in Dermatology Recognized Again Fancy yourself a star in dermatology? Well, take notes from Dr. Monib A. Zirvi. The guy just got his due recognition from Marquis Who's Who for his sizable contributions to dermatology and research. For someone who's been at this game for over two decades, Zirvi doesn't just glide by on old merits. He's the real deal, and his...

Shareholder Rights in Focus: Examining Key Buyouts

Shareholder Concerns Rise Amid Corporate Buyouts The stakes are high for the shareholders of Distribution Solutions Group, Eagle Financial Services, Safety Insurance Group, and Utz Brands as their companies face potential buyouts. Let's chew over what's on the table: the sweet deals insiders might score and the legal maneuvers in play. Halper Sadeh LLC, a heavy-hitting...

Health Net's $2M Boost for Stanislaus Affordable Housing

Joining the Fight Against California’s Housing Crisis Well, I'll be the first to say it's a breath of fresh air when a healthcare beast like Health Net starts investing in something as critical as affordable housing. This is no drop in the bucket—two million dollars is quite the commitment to fix some of the mess that’s been brewing in Stanislaus County, California....